Sol-Gel Technologies Ltd.

SLGL | NASDAQ

Price Alert Chart Builder DCF Calculator

$60.95

+$1.67 (+2.82%)

At close: Sep 22, 2026, 4:00 PM ET

$60.85

-$0.10 (-0.16%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.82%

(1D)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $199.24M

1D Range

60.50 62.88

52W Range

27 97.97

Valuation (TTM)

PE -10.51

PB 4.03

EV/EBITDA -8.44

Valuation (NTM)

Forward PE N/A

Forward PEG -0.77

Price Target $110

Cash Flow

FCF Yield 0.0%

SBC Adj. FCF Yield -1.1%

SBC Impact N/A

Margins

Gross Margin 100.0%

Operating Margin -987.0%

FCF Margin 0.0%

Growth (CAGR)

Revenue 3Y | 5Y 1.6% | -20.9%

Dil EPS 3Y | 5Y -300.0% | -85.7%

FCF 3Y | 5Y 150.0% | 55.4%

Returns

ROA -30.4%

ROE -44.0%

ROIC -35.9%

Financial Health

Net Cash

$47.41M

Current Ratio 10.37

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage t...

Sector Healthcare

Industry Biotechnology

Employees 28

IPO Date Jan 31, 2018

Website www.sol-gel.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 19, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$110

Upside

+80.48%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞